These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 4144788)

  • 21. The effect of racemic propranolol, dextro-propranolol and racemic practolol on the human and canine cardiac transmembrane action potential (beta blockade and the cardiac action potential).
    Coltart DJ; Meldrum SJ
    Arch Int Pharmacodyn Ther; 1971 Jul; 192(1):188-97. PubMed ID: 4398411
    [No Abstract]   [Full Text] [Related]  

  • 22. Cardiovascular effects of acebutolol (M & B 17803A), in exercising man; a comparative study with practolol and propranolol.
    Coleman AJ; Leary WP
    Curr Ther Res Clin Exp; 1972 Oct; 14(10):673-8. PubMed ID: 4404477
    [No Abstract]   [Full Text] [Related]  

  • 23. [Pindolol. New beta blocking agent. Effect on cardiac chronotropism and ionotropism and comparison of its activity with propranolol].
    Aquaro G; Baduini G; Pavia M; Poletti T
    Minerva Cardioangiol; 1972 Jun; 20(6):324-9. PubMed ID: 4402731
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical assessment of practolol in coronary heart disease.
    Sznajderman M; Wasowska-Ciszek T; Jarecki M; Januszewicz W
    Acta Med Pol; 1973; 14(1):27-33. PubMed ID: 4144420
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effects of trimepranol and propranolol in thyreotoxicosis and in patients with arrhythmia].
    Vána S; Felt V; Nĕmec J; Zamrazil V
    Cas Lek Cesk; 1972 Jun; 111(20):454-9. PubMed ID: 4402995
    [No Abstract]   [Full Text] [Related]  

  • 26. [Specific differences between the adrenergic beta receptors of the heart and coronary vessels].
    Bayer BL; Mentz P; Förster W
    Arch Int Pharmacodyn Ther; 1972 Dec; 200(2):341-7. PubMed ID: 4405155
    [No Abstract]   [Full Text] [Related]  

  • 27. Measurement of hydrophobicity, surface activity, local anaesthesia, and myocardial conduction velocity as quantitative parameters of the non-specific membrane affinity of nine -adrenergic blocking agents.
    Hellenbrecht D; Lemmer B; Wiethold G; Grobecker H
    Naunyn Schmiedebergs Arch Pharmacol; 1973; 277(2):211-26. PubMed ID: 4145013
    [No Abstract]   [Full Text] [Related]  

  • 28. Cardiospecificity of -receptor blockade. A comparison of the relative potencies on cardiac and peripheral vascular -adrenoceptors of propranolol, of practolol and its ortho-substituted isomer, and of oxprenolol and its para-substituted isomer.
    Williams EM; Bagwell EE; Singh BN
    Cardiovasc Res; 1973 Mar; 7(2):226-40. PubMed ID: 4144352
    [No Abstract]   [Full Text] [Related]  

  • 29. [Is Practolol (ICI-50172) a cardioselective beta-blockader?].
    Lanser KG; Siemssen S; Sill V
    Z Kardiol; 1973 Jan; 62(1):80-8. PubMed ID: 4145736
    [No Abstract]   [Full Text] [Related]  

  • 30. Pharmacodynamic studies of beta adrenergic antagonism induced in man by propranolol and practolol.
    Bodem G; Brammell HL; Weil JV; Chidsey CA
    J Clin Invest; 1973 Apr; 52(4):747-54. PubMed ID: 4144332
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potentiation of bronchomotor responses by beta adrenergic antagonists.
    Diamond L
    J Pharmacol Exp Ther; 1972 Jun; 181(3):434-45. PubMed ID: 4402373
    [No Abstract]   [Full Text] [Related]  

  • 32. Cardiac toxicity of -lytic drugs.
    Roba J
    Arch Int Pharmacodyn Ther; 1972 Apr; 196():Suppl 196:120-. PubMed ID: 4403294
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparison of beta-adrenergic blocking activities of propranolol, isopropylmethoxamine, sotalol, practolol, alprenolol, pindolol, oxprenolol and D-32 in the atria and trachea of the guinea-pig.
    Horii D; Kawada T; Takeda K; Imai S
    Arzneimittelforschung; 1974 Sep; 24(9):1275-7. PubMed ID: 4154764
    [No Abstract]   [Full Text] [Related]  

  • 34. [Hemodynamic changes following blockade of the beta-receptors in healthy persons and in patients with coronary heart disease. Comparison between Trasicor and Inderal].
    Bürgin D
    Schweiz Med Wochenschr; 1968 Jun; 98(25):940-5. PubMed ID: 5699197
    [No Abstract]   [Full Text] [Related]  

  • 35. [On the treatment of angina pectoris with beta-blocking agents (Eraldin, Visken)].
    Mihail A; Popescu P; Ioan A; Bruckner I; Paraschiv A; Petrescu X; Popa N
    Med Interna (Bucur); 1973 Jan; 25(1):87-93. PubMed ID: 4144020
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effect of practolol on post-digitalis dynamics of left ventricular contraction and on ventricular arrhythmia in patients with toxic concentration of digitoxin in plasma].
    Adamska-Dyniewska H
    Pol Tyg Lek; 1971 Nov; 26(47):1818-20. PubMed ID: 5132741
    [No Abstract]   [Full Text] [Related]  

  • 37. Cardioselective beta-adrenergic blockade.
    Fitzgerald JD
    Proc R Soc Med; 1972 Sep; 65(9):761-4. PubMed ID: 4404402
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparative partial agonist activity of -adrenoceptor antagonists.
    Nayler WG
    Br J Pharmacol; 1972 Jun; 45(2):382-4. PubMed ID: 4403104
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The selectivity of -adrenergic compounds. II. Studies on the mimetic compound Salbutamol and the lytic compound practolol.
    Grana E; Mastelli OC; Zonta F; Lucchelli A; Santagostino MG
    Farmaco Sci; 1972 Oct; 27(10):842-54. PubMed ID: 4404432
    [No Abstract]   [Full Text] [Related]  

  • 40. [Effects of a heart specific beta blockader (practolol) following acute experimental coronary occlusion].
    Stephan K; Meesmann W; Amann L; Tacke E; Tüttemann J
    Verh Dtsch Ges Inn Med; 1972; 78():1029-33. PubMed ID: 4146706
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.